Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AbbVie

Abbott Labs

AvalonBay Communities

Brookfield Asset Management

Brookfield Renewable Partners

Brookfield Infrastructure Partners L.P.

Brookfield Infrastructure

Crown Castle International

Digital Realty Trust

Con Ed

Enbridge

Enterprise Products Partners

Gilead Sciences

Intel

Johnson & Johnson

Medical Properties Trust

Realty Income Corp

Pfizer

Procter & Gamble

Viatris

Verizon

W. P. Carey

A list of high-yielding dividend stocks to consider buying now.

20 High-Yield Dividend Stocks to Buy in 2023

Walgreens Boots Alliance, Inc. reported weak fiscal Q1 2023 results - mostly due to $6.5 billion litigation associated with opioid settlements. And although there are many short-term reasons not to own Walgreens Boots Alliance right now, it is a good long-term investment.

Am I Wrong About Walgreens Boots Alliance?

Net loss in Q1 driven by the $6.5 billion pre-tax charge recognized in connection with the previously announced opioid litigation settlement frameworks. Increased CAPEX also resulted in negative free cash flow.

Should You Sell Walgreens Boots Alliance Because Of The Q1 Loss?

Algonquin Power & Utilities

JPMorgan Equity Premium Income ETF

New York Community Bancorp

PIMCO Dynamic Income Fund

PIMCO Corporate & Income Opportunity Fund

The Dividend Harvesting Portfolio is now generating $758.88 in annual dividends, yielding 7.6%. The Dividend Harvesting portfolio has a 73.47% record of finishing the week in the black since its inception, 72/98 weeks.

Dividend Harvesting Portfolio Week 98 Update: $9.8K Allocated, $759 Projected Dividends

Walgreens is going to focus more on growing its new healthcare business.

Walgreens Is Slowing Down M&A. Should Investors Be Worried?

Ameriprise Financial

APA Corporation

Exelon

Morgan Stanley

For years, it seems analysts and portfolio managers have anticipated the return of value stocks as the market has moved higher, and for years they have continued to underperform growth stocks.

Value Crushes Growth to Start 2023: 7 Defensive ‘Strong Buy' Stocks With Big Dividends

West Virginia—which has the nation's highest overdose death rate—has already reached settlements with other pharmacies, including Rite Aid and CVS, in similar litigation.

Walgreens Strikes $83 Million Settlement With West Virginia Over Opioid Crisis

These stocks both provide investors with some mouth-watering yields.

Walgreens or Medical Properties: Which Is the Better Dividend Stock?

Alliance Resource Partners

AT&T

These income stocks, with yields ranging from 5.2% to 9.7%, are exceptionally inexpensive and ripe for the picking by opportunistic investors.

3 of the Cheapest High-Yield Dividend Stocks on the Planet to Buy Right Now

Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock recovered some sell-off losses from its fiscal Q1 2023 earnings

Is Walgreens Boots Alliance Earnings Miss Good For Investors?

Walgreens Boots Alliance Inc. WBA, -1.25% said Monday that it removed restrictions on purchases of over-the-counter children's cold medications. The pharmacy retail giant in December limited purchases of fever-reducing medicines during a surge in pediatric cases of respiratory syncytial virus, flu, and COVID-19 that began in the fall.

Walgreens lifts restrictions on purchases of children's cold medicines

Ellington Residential Mortgage REIT

Eagle Point Credit

Stone Harbor Emerging Markets Total Income Fund

FS KKR Capital Corp

Genco Shipping & Trading

Himax Tech

ProShares K-1 Free Crude Oil Strategy ETF

Orchid Island Capital

Oxford Lane Capital

Oxford Lane Capital Corp 6.75 % Cum Red Pfd Shs Series -2024-

Sirius XM Holdings Inc

ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN

Trinity Capital

Credit Suisse X-Links Crude Oil Shares Covered Call ETN

Prior to December 30, 2022, readers mentioned 40 equities in their recent comments. Some lamented bad news, so bad news investments (rogues) mixed with (mostly) favorites. (Thus, these are ReFa/Ro.). Ten analyst-target-estimated top-net-gain Re/Fa/Ro: OILK, VZ, EARN, WBA, HIMX, FSK, USOI, TRIN, GNK, and ORC, averaged 34.13% net gains from data collected 1/9/23.

Readers Reveal 30 Ideal December Dividend Dogs

CVS Health

Dillard's

Macy's

Overstock.com

Consumer data showing signs of deflation on a month-to-month basis is promising for the broader stock market. This is especially significant for the Retail and Wholesale sector and a stronger consumer could lead to more upside in these five stocks.

5 Retail Stocks That Could Rally on Lower Inflation

PIMCO Dynamic Income Opportunities Fund

Virtus InfraCap U.S. Preferred Stock ETF

Starwood Property

The Dividend Harvesting Portfolio is now generating $745.52 in annual dividends, yielding 7.74%. The Dividend Harvesting portfolio has a 73.2% record of finishing the week in the black since its inception, 71/97 weeks.

Dividend Harvesting Portfolio Week 97 Update: $9,700 Allocated, $745.52 Projected Annual Dividends

DEERFIELD, Ill.--( BUSINESS WIRE )--Teenagers nationwide can begin submitting entries for the 13th Annual Expressions by Walgreens, an artistic challenge for high school students that awards monetary prizes in four categories: visual arts, media arts, spoken word, and creative writing. Entries are being accepted now through March 31, 2023.

Thirteenth Annual Expressions by Walgreens High School Art Challenge Opens for Entries

Among the Dow Jones Industrial Average's 30 components, there are three supercharged dividend stocks begging to be bought.

3 High-Yield Dow Stocks That Are Screaming Buys in 2023

The retail pharmacy chain offers a 5.2% dividend yield, but the company also posted a huge loss recently.

Should You Sell Walgreens Boots Alliance Stock?

Cisco Systems

Amdocs

Nutrien

QUALCOMM

Investors who want to build a portfolio's value over time will seek quality companies. Those stocks to buy have thriving businesses with proven returns on their investments.

7 Stocks to Buy for the $100,000 Portfolio

Canadian Natural Resources

Duke Energy

The pandemic-era investing of trading fun and games is long over. Like last year, 2023 may be another year when the tab comes due, and it could be expensive.

2022 Best Stocks and Sectors That Pay Big Dividends Look Poised to Win Again in 2023

News for Walgreens Stock (WBA)